Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acorda Therapeutics, Inc.
Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organization BIO
July 18th, 2008
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced President and CEO Ron Cohen, M.D. has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO). Dr. Cohen was also named Vice Chair of the Emerging Companies Section of BIO. BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. "BIO serves a critical role in promoting the discovery and development of new technologies in various biotechnology fields," said Dr. Cohen. "It is a privilege to serve the organization in this new capacity and I look forward to helping BIO fulfill its...
Source: Health Business Week (2008-07-18)
|
